A novel strategy for the management of lung congestion: targeting TRPV4 channel, the ‘gate keeper’ of pulmonary capillary permeability
- 30 April 2020
- journal article
- editorial
- Published by Wiley in European Journal of Heart Failure
- Vol. 22 (9), 1646-1648
- https://doi.org/10.1002/ejhf.1849
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Journal of Heart Failure, 2016
- Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patientsEuropean Heart Journal, 2016
- Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implicationsEuropean Journal of Heart Failure, 2015
- TRPV4: physiological role and therapeutic potential in respiratory diseasesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2014
- An Orally Active TRPV4 Channel Blocker Prevents and Resolves Pulmonary Edema Induced by Heart FailureScience Translational Medicine, 2012
- Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure?Circulation: Heart Failure, 2012
- High Vascular Pressure–Induced Lung Injury Requires P450 Epoxygenase–Dependent Activation of TRPV4American Journal of Respiratory Cell and Molecular Biology, 2008
- TRPV4 initiates the acute calcium-dependent permeability increase during ventilator-induced lung injury in isolated mouse lungsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Pulmonary Microvascular PermeabilityCirculation Research, 1995